This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Discovery Corporation Selected As “Best & Brightest” Small Cap Company By MDB Capital Group And Expands Patent Portfolio

Health Discovery Corporation (OTCBB: HDVY) announced today that the Company has been listed among the “Best & Brightest” qualifying small cap companies by MDB Capital Group LLC.

According to MDB Capital Group, the Bright Lights Conference will showcase the untold IP stories of 50 public companies ranking in the 90th percentile for technology leadership from over 1,600 small cap companies with U.S. patents granted, as rated by PatentVest, MDB's proprietary IP business intelligence database. The 1st Annual Bright Lights Conference will be held on May 10 - 12, 2010 at the Palace Hotel in San Francisco. Institutional investors from several countries, as well as IP thought leaders, will be in attendance for the first public company conference to focus exclusively on selected companies with disruptive and market changing Intellectual property.

“We are honored to have been selected by MDB Capital Group as one of the top companies from more than 1,600 small cap companies scored, ranked and analyzed on the basis of the rate of innovative change, as well as, the novelty, quality and industry impact of our patents," said Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation. “This recognition confirms what we have known for years, that HDC's valuable SVM technology and robust patent portfolio gives our Company a major market advantage,” said Dr. Barnhill.

Health Discovery Corporation is also pleased to announce that it has expanded its already strong IP portfolio (41 issued patents and 33 pending patents) by filing new patent applications covering its recently announced mobile phone application for melanoma screening and the broad use of SVMs for analysis of spectral data, as well as filing for additional international protection for the four-gene prostate cancer test and analysis algorithm that the Company has licensed to Quest Diagnostics, Abbott Laboratories and Clarient.

MDB Capital Group LLC is an institutional research and investment banking firm that focuses exclusively on companies that possess market changing, disruptive intellectual property.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
HDVY $0.02 0.00%
AAPL $124.75 0.00%
FB $80.78 0.00%
GOOG $524.05 0.00%
TSLA $206.79 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs